Metropolitan Life Insurance Company (MetLife)’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,518
| Closed | -$26.4K | – | 1418 |
|
|
2024
Q1 | $26.4K | Hold |
5,518
| – | – | ﹤0.01% | 1724 |
|
|
2023
Q4 | $26.5K | Buy |
5,518
+749
| +16% | +$4.58K | ﹤0.01% | 1785 |
|
|
2023
Q3 | $34.5K | Hold |
4,769
| – | – | ﹤0.01% | 1602 |
|
|
2023
Q2 | $35.4K | Buy |
+4,769
| New | +$37.5K | ﹤0.01% | 1634 |
|
|
2022
Q1 | – | Sell |
-5,015
| Closed | -$717K | – | 2538 |
|
|
2021
Q4 | $717K | Buy |
5,015
+63
| +1% | +$10.8K | 0.01% | 1186 |
|
|
2021
Q3 | $1.03M | Sell |
4,952
-162
| -3% | -$35.7K | 0.01% | 924 |
|
|
2021
Q2 | $1.09M | Sell |
5,114
-11,368
| -69% | -$2.08M | 0.02% | 950 |
|
|
2021
Q1 | $2.99M | Sell |
16,482
-645
| -4% | -$129K | 0.04% | 351 |
|
|
2020
Q4 | $1.91M | Sell |
17,127
-544
| -3% | -$57.8K | 0.03% | 499 |
|
|
2020
Q3 | $1.91M | Sell |
17,671
-23
| -0.1% | -$2.8K | 0.03% | 428 |
|
|
2020
Q2 | $1.47M | Buy |
17,694
+8,461
| +92% | +$324K | 0.03% | 531 |
|
|
2020
Q1 | $125K | Buy |
+9,233
| New | +$78.1K | ﹤0.01% | 1883 |
|
|
2019
Q1 | – | Sell |
-6,864
| Closed | -$253K | – | 2565 |
|
|
2018
Q4 | $253K | Hold |
6,864
| – | – | 0.01% | 1649 |
|
|
2018
Q3 | $258K | Hold |
6,864
| – | – | ﹤0.01% | 1836 |
|
|
2018
Q2 | $184K | Buy |
6,864
+1,992
| +41% | +$67.3K | ﹤0.01% | 1993 |
|
|
2018
Q1 | $205K | Buy |
4,872
+1,300
| +36% | +$52.2K | ﹤0.01% | 1878 |
|
|
2017
Q4 | $89K | Sell |
3,572
-5,233
| -59% | -$128K | ﹤0.01% | 2371 |
|
|
2017
Q3 | $201K | Sell |
8,805
-1,245
| -12% | -$27.9K | ﹤0.01% | 2270 |
|
|
2017
Q2 | $231K | Hold |
10,050
| – | – | ﹤0.01% | 2246 |
|
|
2017
Q1 | $257K | Sell |
10,050
-150
| -1% | -$4.13K | ﹤0.01% | 2101 |
|
|
2016
Q4 | $257K | Buy |
10,200
+285
| +3% | +$8.31K | ﹤0.01% | 2185 |
|
|
2016
Q3 | $412K | Sell |
9,915
-202
| -2% | -$26.1K | ﹤0.01% | 1822 |
|
|
2016
Q2 | $1.47M | Buy |
10,117
+99
| +1% | +$11.3K | 0.01% | 1055 |
|
|
2016
Q1 | $1.03M | Buy |
10,018
+780
| +8% | +$83.7K | 0.01% | 1157 |
|
|
2015
Q4 | $1.55M | Buy |
9,238
+132
| +1% | +$20.3K | 0.01% | 986 |
|
|
2015
Q3 | $1.29M | Sell |
9,106
-513
| -5% | -$115K | 0.01% | 1066 |
|
|
2015
Q2 | $2.14M | Buy |
9,619
+318
| +3% | +$55.9K | 0.02% | 943 |
|
|
2015
Q1 | $1.54M | Sell |
9,301
-24
| -0.3% | -$3.9K | 0.01% | 985 |
|
|
2014
Q4 | $1.11M | Hold |
9,325
| – | – | 0.01% | 1279 |
|
|
2014
Q3 | $778K | Buy |
9,325
+1,532
| +20% | +$138K | 0.01% | 1434 |
|
|
2014
Q2 | $720K | Hold |
7,793
| – | – | 0.01% | 1571 |
|
|
2014
Q1 | $706K | Hold |
7,793
| – | – | ﹤0.01% | 1577 |
|
|
2013
Q4 | $798K | Buy |
7,793
+2,272
| +41% | +$161K | 0.01% | 1488 |
|
|
2013
Q3 | $349K | Buy |
5,521
+2,152
| +64% | +$121K | ﹤0.01% | 1995 |
|
|
2013
Q2 | $138K | Buy |
+3,369
| New | +$146K | ﹤0.01% | 2601 |
|
Other funds holding NVAX
SCM
Metropolitan Life Insurance Company (MetLife)'s NVAX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Novavax (NVAX) in Q2 2024, closing a stake of 5,518 shares — an estimated $26.4K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in NVAX in Q2 2013 and held it in 35 quarters. The position peaked at $2.99M in Q1 2021. 230 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 5,518 Novavax shares in Q2 2024, an estimated $26.4K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Novavax in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Novavax position peaked at $2.99M in Q1 2021.
- 230 funds tracked by Wall St. Rank held Novavax as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.